TEVA PHARMACEUTICALS USA v. CORCEPT THERAPEUTICS

2021-1360.

18 F.4th 1377 (2021)

TEVA PHARMACEUTICALS USA, INC., Appellant v. CORCEPT THERAPEUTICS, INC., Appellee.

United States Court of Appeals, Federal Circuit.

Decided: December 7, 2021.


Attorney(s) appearing for the Case

John Christopher Rozendaal , Sterne Kessler Gold-stein & Fox, PLLC, Washington, DC, argued for appellant. Also represented by Uma Everett , William Milliken , Olga A. Partington , Deborah Sterling .

Eric C. Stops , Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for appellee. Also represented by William Adams , Frank Charles Calvosa , Francis Dominic Cerrito , Daniel C. Wiesner .

Before MOORE, Chief Judge, NEWMAN and REYNA, Circuit Judges.


In a final-written decision, the Patent Trial and Appeal Board held that Teva Pharmaceuticals USA had failed to show claims 1-13 of U.S. Patent No. 10,195,214 would have been obvious. Teva Pharms. USA, Inc. v. Corcept Therapeutics, Inc., PGR2019-00048, 2020 WL 6809812 (P.T.A.B. Nov. 18, 2020) (Final Decision). Teva...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases